Marpai (NASDAQ:MRAI) and Quipt Home Medical (NASDAQ:QIPT) Financial Survey

Marpai (NASDAQ:MRAI) and Quipt Home Medical (NASDAQ:QIPT) are both small-cap business services companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, profitability, risk, earnings, analyst recommendations, dividends and valuation.

Analyst Recommendations

This is a summary of current ratings and recommmendations for Marpai and Quipt Home Medical, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Marpai	0	0	1	0	3.00
Quipt Home Medical	1	0	3	2	3.00

Marpai currently has a consensus target price of $6.00, suggesting a potential upside of 552.17%. Quipt Home Medical has a consensus target price of $6.25, suggesting a potential upside of 111.86%. Given Marpai’s higher possible upside, research analysts plainly believe Marpai is more favorable than Quipt Home Medical.

Institutional and Insider Ownership

49.8% of Marpai shares are held by institutional investors. Comparatively, 42.9% of Quipt Home Medical shares are held by institutional investors. 61.3% of Marpai shares are held by insiders. Comparatively, 13.4% of Quipt Home Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Volatility & Risk

Marpai has a beta of 5.02, suggesting that its stock price is 402% more volatile than the S&P 500. Comparatively, Quipt Home Medical has a beta of 0.57, suggesting that its stock price is 43% less volatile than the S&P 500.

Profitability

This table compares Marpai and Quipt Home Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Marpai	-85.70%	N/A	-100.23%
Quipt Home Medical	-2.66%	-6.18%	-2.73%

Earnings & Valuation

This table compares Marpai and Quipt Home Medical”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Marpai	$37.15 million	0.35	-$28.75 million	($2.64)	-0.35
Quipt Home Medical	$245.91 million	0.52	-$6.76 million	($0.15)	-19.67

Quipt Home Medical has higher revenue and earnings than Marpai. Quipt Home Medical is trading at a lower price-to-earnings ratio than Marpai, indicating that it is currently the more affordable of the two stocks.

Summary

Quipt Home Medical beats Marpai on 8 of the 14 factors compared between the two stocks.

About Marpai

Marpai, Inc., a technology-driven healthcare payer, focuses on providing services to the self-insured employer market in the United States and Israel. The company offers ancillary services, such as care management, case management, actuarial services, bill review and cost containment services. Marpai, Inc. was incorporated in 2021 and is based in Tampa, Florida.

About Quipt Home Medical

Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment. It offers management of various chronic disease states focusing on patients with heart and pulmonary disease, sleep apnea, reduced mobility, and other chronic health conditions. The company was formerly known as Protech Home Medical Corp. and changed its name to Quipt Home Medical Corp. in May 2021. Quipt Home Medical Corp. is headquartered in Wilder, Kentucky.